Please login to the form below
Lundbeck
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lundbeck's 2013 CNS (central nervous system) sales performance.
Lundbeck to cut 1,000 jobs in major restructure
I believe the restructuring programme announced today is necessary and will make Lundbeck drive sustainable value creation for all our stakeholders.”. ... Lundbeck said final estimates for its programme costs and benefits, and their impact of headcount,
US filing aims to elevate Brintellix above its competition
Lundbeck and Takeda have filed for US approval of new labelling for their antidepressant Brintellix that suggests the drug can improve cognitive function in patients. ... Lundbeck and Takeda need something to help Brintellix gain headway in the fiercely
Is bigger always better in clinical outsourcing?
Speaking at the recent Clinical Outsourcing World conference in London, Dorte Arnbjerg, vice president of global study management at Lundbeck, said it is worth questioning whether bigger is always better and -
Lundbeck and Otsuka's Rexulti set for August launch in US
Follows the antipsychotic drug's FDA approval on Friday. A new antipsychotic drug developed by Lundbeck and Otsuka looks set to debut in the US in August after gaining FDA approval ... Kåre Schultz, Lundbeck's chief executive, said: "All treatment
Target the impact of depression in the workplace
by Ogilvy HealthPR for H. Lundbeck A/S. For the first time, a group of 13 multinational companies, collectively employing more than one million people, have joined together forming ‘Target Depression’ ... Lundbeck A/S specialises in brain diseases
[ Previous 5 results ] 11 12 13 14 15 16 17 18 19 20 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Manager
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- MHRA to introduce new UK clinical trials framework
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Janssen’s single tablet combination shows promise in phase 3 PAH study
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- How to make sure your adverts for clinical trials are compliant
PMHub
The Creative Engagement Group
We create experiences that inspire lasting change. Exceptional experiences that engage people, change mindsets and behaviour, enrich cultures, increase skills...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
